N. Villanueva - Concepedia

Author

N. Villanueva

Hospital Universitario Central de Asturias ORCID

Also Known As

N. Villanueva, Niño Jesse S Villanueva, Noemi Villanueva, Noemí Villanueva, Noemí Villanueva (632852), Noemı́ Villanueva, Zevallos Villanueva, Nicole Kimberly

Publications

453

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Central de Asturias Hospital Clínico San Carlos Eastern State Hospital University of Kentucky Universidad de Oviedo

About

N. Villanueva is an author at Hospital Universitario Central de Asturias specializing in medicine, cancer therapeutics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	198
2	Pathology	2	2	36
3	Pharmacology	2	2	37
4	Health Sciences	1	1	15
5	Anesthesia	1	1	18

N. Villanueva

Publications

416

Citations

H-Index

Page 1

	Year	Citations
Obesity and Associated Complications in Patients With Severe Mental Illnesses Margaret T. Susce, N. Villanueva, Francisco J. Díaz, The Journal of Clinical Psychiatry	2005	129
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial Solange Peters, Jean-Louis Pujol, Urania Dafni, Annals of Oncology OncologyImmune Checkpoint InhibitorConsolidation NivolumabCancer TreatmentIpilimumab Versus Observation	2021	105
Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemistry Esther Conde, Ana Suárez‐Gauthier, Amparo Benito, PLoS ONE	2014	65
Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study Emilio Esteban, N. Villanueva, I. Muñiz, Investigational New Drugs OncologyMedicinePulmonary PharmacologyPulmonary MedicinePharmacotherapy	2007	24
Prolonged Clinical Benefit of Everolimus Therapy in the Management of High-Grade Pancreatic Neuroendocrine Carcinoma Paula Jiménez Fonseca, E. Uriol, José A. Galván, Case Reports in Oncology Prolonged Clinical BenefitEverolimus TherapySurgical OncologyUrologyPancreatic Cancer	2013	23
Incontinence during treatment with gabapentin António Gil‐Nagel, Sabina Gapany, K. Blesi, Neurology UrologyVoiding DysfunctionPelvic ProlapseFemale UrologyUrogynecology	1997	18
Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study Emilio Esteban, J. Fra, Yolanda Fernández, Investigational New Drugs MedicinePhase Ii StudyBronchial NeoplasmFirst-line TreatmentVersus Cisplatin	2005	15
Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes R. Sosa Sanchez, Emilio Esteban, Isabel Palacio, Investigational New Drugs Weekly IrinotecanMedicinePharmacologyPathologyBronchial Neoplasm	2003	13
Probable Association Between Ziprasidone and Worsening Hypertension N. Villanueva, Courtney Markham-Abedi, Connie Mcneely, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2006	13
Pegylated Liposomal Doxorubicin and Gemcitabine in a Fixed Dose Rate Infusion for the Treatment of Patients With Poor Prognosis of Recurrent Ovarian Cancer Guillermo Crespo, Marta Sierra, Raquel Losa, International Journal of Gynecological Cancer	2011	11

Page 1